Literature DB >> 10725660

Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition.

E C Friedberg1, J P Bond, D K Burns, D L Cheo, M S Greenblatt, L B Meira, D Nahari, A M Reis.   

Abstract

Mice that are genetically engineered are becoming increasingly more powerful tools for understanding the molecular pathology of many human hereditary diseases, especially those that confer an increased predisposition to cancer. We have generated mouse strains defective in the Xpc gene, which is required for nucleotide excision repair (NER) of DNA. Homozygous mutant mice are highly prone to skin cancer following exposure to UVB radiation, and to liver and lung cancer following exposure to the chemical carcinogen acetylaminofluorene (AAF). Skin cancer predisposition is significantly augmented when mice are additionally defective in Trp53 (p53) gene function. We also present the results of studies with mice that are heterozygous mutant in the Apex (Hap1, Ref-1) gene required for base excision repair and with mice that are defective in the mismatch repair gene Msh2. Double and triple mutant mice mutated in multiple DNA repair genes have revealed several interesting overlapping roles of DNA repair pathways in the prevention of mutation and cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725660     DOI: 10.1016/s0921-8777(99)00068-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  24 in total

1.  Rous-Whipple Award Lecture. Nucleotide excision repair and cancer predisposition: A journey from man to yeast to mice.

Authors:  E C Friedberg
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population.

Authors:  Mehmet Burak Aktuglu; Mesut Ayer; Elif S Bireller; Cagla Rencuzogullari; Hasan Acik; Zeynep Karaali; Taner Alioglu; Namik Yigit; Mustafa Velet; Eray Atalay; Oznur Sari Ure; Bedia Cakmakoglu
Journal:  Med Oncol       Date:  2014-08-26       Impact factor: 3.064

3.  Epidermal transit of replication-arrested, undifferentiated keratinocytes in UV-exposed XPC mice: an alternative to in situ apoptosis.

Authors:  Gerdine J Stout; Daniel Westdijk; Dennis M Calkhoven; Olaf Pijper; Claude M P Backendorf; Rein Willemze; Leon H F Mullenders; Frank R de Gruijl
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 4.  Deconstructing networks of p53-mediated tumor suppression in vivo.

Authors:  Alyssa M Kaiser; Laura D Attardi
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

5.  Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis.

Authors:  M Christine Hollander; Robyn T Philburn; Andrew D Patterson; Susana Velasco-Miguel; Errol C Friedberg; R Ilona Linnoila; Albert J Fornace
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

6.  The role of XPC: implications in cancer and oxidative DNA damage.

Authors:  Joost P M Melis; Mirjam Luijten; Leon H F Mullenders; Harry van Steeg
Journal:  Mutat Res       Date:  2011-07-07       Impact factor: 2.433

Review 7.  Molecular regulation of UV-induced DNA repair.

Authors:  Palak Shah; Yu-Ying He
Journal:  Photochem Photobiol       Date:  2015-01-14       Impact factor: 3.421

8.  Error-prone translesion replication of damaged DNA suppresses skin carcinogenesis by controlling inflammatory hyperplasia.

Authors:  Anastasia Tsaalbi-Shtylik; Johan W A Verspuy; Jacob G Jansen; Heggert Rebel; Leone M Carlée; Martin A van der Valk; Jos Jonkers; Frank R de Gruijl; Niels de Wind
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

9.  Unravelling mechanisms of p53-mediated tumour suppression.

Authors:  Kathryn T Bieging; Stephano Spano Mello; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2014-04-17       Impact factor: 60.716

10.  Genetic Evidence for XPC-KRAS Interactions During Lung Cancer Development.

Authors:  Xiaoli Zhang; Nonggao He; Dongsheng Gu; Jeff Wickliffe; James Salazar; Istavan Boldogh; Jingwu Xie
Journal:  J Genet Genomics       Date:  2015-10-17       Impact factor: 4.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.